why choose us

First received: May 29, 2024

Clinical Trial: A Study to Evaluate the Effect of Povorcitinib on the QT/QTc Interval in Healthy Participants

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Healthy Participants

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Randomized, Partially Double-Blind, Placebo- and Positive-Controlled, Parallel Study to Evaluate the Effect of Povorcitinib on the QT/QTc Interval in Healthy Participants

Brief Summary: The purpose of this study is to evaluate the effect of povorcitinib on the QT/QTc Interval in healthy participants.

Read more